The global aptamers market is expected to reach USD 8.91 billion by 2025 according to a new report by Grand View Research, Inc. Advancements in aptamer development technologies, increasing R&D, and rising number of companies investing in this market are some of the key driving factors responsible for the growth of this market.
Numerous
advantages offered by these small molecules in comparison to established
antibodies have also led to higher demand for these molecules across a diverse
range of medical applications. They are chemically synthesized, which
eliminates batch-to-batch variation and demands less time for development.
Along with this, continuous advancement in technologies is expected to
stimulate growth. Integrated DNA Technologies, Inc. introduced a
next-generation product, Ultramers that contain aptamer template length up to
200 bases. According to the company, this new product will be apt for
biotechnology applications such as gene and clone construction. Thus, new
developments in this field are expected to boost usage of these products in
different application areas, thereby driving market growth.
Furthermore,
growing incidence of life-threatening diseases such as cancer has directed many
companies to introduce new & effective detection assays based on aptamer
therapy. In March 2017, Aptamer Sciences, Inc. unveiled multiprotein biomarker
assay by using this technology for the detection of lung cancer. This kit is
designed for early detection and diagnosis of non-small cell lung cancer by
identifying a suitable biomarker. Such types of new product launches are
expected to trigger the acceptance of these therapies, leading to market growth
to a great extent. In addition, increasing number of small-scale startups,
government organizations, rising number of products under clinical
investigation, and growing number of academic research laboratories investigating
the potential of aptamers are anticipated to support future growth of this
market.
In
contrast, many aptamers have failed to meet the requisite safety and efficacy
standards in clinical studies. Thus, companies have to terminate the clinical
investigation during late-stage clinical studies. This factor is likely to
affect growth of this market negatively. In addition, other factors such as low
awareness about these technologies in middle- & low-income countries and
inadequate regulatory structure may hamper the overall growth.
For Full Research Report On Aptamers Market Visit Here:
https://www.grandviewresearch.com/industry-analysis/aptamers-industry
Further Key
Findings from the Report Suggest:
- The nucleic acid aptamer
segment held majority of the revenue share in 2016 due to rise in demand
for nucleic acid-based diagnostic kits and therapeutics across the globe
- Diagnostics application
dominated the application segment in 2016 due to introduction of novel
diagnostic kits by key players
- Developed regions such as
North America and Europe dominated the global market due to growing demand
for aptamer therapeutics coupled with rise in number of research
laboratories
- Some of the key players
include Aptamer Group; Aptamer Sciences, Inc.; Aptagen, LLC; Base Pair
Biotechnologies, Inc.; Ophthotech Corporation; and others
Request a Sample Copy of the Report @
https://www.grandviewresearch.com/industry-analysis/aptamers-industry/request/rs1
Grand View Research has segmented
the aptamers market on the basis of types, application, and region:
Aptamers Types
Outlook (Revenue, USD Million, 2014 - 2025)
- Nucleic Acid
- Peptide
Aptamers
Application Outlook (Revenue, USD Million, 2014 - 2025)
- Diagnostics
- Therapeutics
- Research and Developments
- Others
Aptamers Regional
Outlook (Revenue, USD Million, 2014 - 2025)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- Asia Pacific
- China
- Japan
- Latin America
- Brazil
- Mexico
- Middle East & Africa
- South Africa
About Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, we offer
market intelligence studies ensuring relevant and fact-based research across a
range of industries, from technology to chemicals, materials and healthcare.
For more info visit @ https://www.grandviewresearch.com
No comments:
Post a Comment